Frequency of hospital acquired pneumonia and its microbiological etiology in medical intensive care unit

被引:6
|
作者
Imran, Muhammad [1 ]
Amjad, Alina [2 ]
Haidri, Fakhir Raza
机构
[1] Shifa Int Hosp, ICU Med, Islamabad, Pakistan
[2] Mil Hosp, Rawalpindi, Pakistan
关键词
Hospital acquired pneumonia; Causative agents; Intensive care unit; Prevalence; HAP; VENTILATOR-ASSOCIATED PNEUMONIA; ATTRIBUTABLE MORTALITY; NOSOCOMIAL INFECTION; EPIDEMIOLOGY; PREVALENCE; OUTCOMES;
D O I
10.12669/pjms.324.8942
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The objectives were to assess the frequency of hospital acquired pneumonia (HAP) in patients admitted to intensive care unit (ICU) and to determine the frequencies of different etiological organisms in these patients. Methods: This was descriptive cross sectional study, which was carried out in medical ICU of Shifa International Hospital Islamabad from January 2013 to January 2014. A total of 1866 patients were admitted in the department of medicine including medical ICU. They were evaluated for HAP and the causative organisms were cultured from these patients. Identification was carried out by standard biochemical profile of the organisms. Results: The total number of patients admitted in medical ICU for any reason were 346. HAP was diagnosed in 88 patients (25.4%). The average age of patients admitted in Medical ICU with HAP was 48 years with the range of 16 to 82 years. 56 were male and 32 females. 42 patients (47.7%) died in medical ICU with HAP. Microbiological analysis showed that Pseudomonas aeruginosa were 27 (30.6%), Acinetobacter spp. were 12 (13.6%), Candida albicans were 12 (13.6%), Klebsiellapneumoniae were 9 (10.2%), Streptococcus spp. were 9 (10.2%), Escherichia coli were 5 (5.6%), Stenotrophomonas spp. were 4(4.5%), Methicillin Resistant Staphylococcus Aureus (MRSA) were 4 (4.5%) others organisms 6 (6.8%). Conclusion: The frequency of HAP in Medical ICU of our hospital is 88 out of 346 (25.4%). The commonest organism identified was Pseudomonas aeruginosa (30.6%) followed by Acinetobacter and Candida albicans (13.6% each).
引用
收藏
页码:823 / 826
页数:4
相关论文
共 50 条
  • [21] Microbiological Profile of Bronchoalveolar Lavage in Patients with Nosocomial Pneumonia in Intensive Care Unit
    Koneru, Kalyani Sri
    Joy, Priya
    Gangadharan, V.
    Kumar, Ashok
    Kumar, Sathish
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2018, 12 (07) : OC9 - OC12
  • [22] Antimicrobial use, incidence, etiology and resistance patterns in bacteria causing ventilator-associated pneumonia in a clinical-surgical intensive care unit
    Moreira, Michel Rodrigues
    Guimaraes, Munick Paula
    de Araujo Rodrigues, Aurelia Aparecida
    Gontijo Filho, Paulo Pinto
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2013, 46 (01) : 39 - 44
  • [23] Disease burden of intensive care unit-acquired pneumonia in China: a systematic review and meta-analysis
    Zhang, Yaowen
    Yao, Zhiyuan
    Zhan, Siyan
    Yang, Zhirong
    Wei, Dong
    Zhang, Jing
    Li, Jingyi
    Kyaw, Moe H.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 29 : 84 - 90
  • [24] Microbiology and prognostic factors of hospital- and community-acquired aspiration pneumonia in respiratory intensive care unit
    Wei, Chaojie
    Cheng, Zhenshun
    Zhang, Li
    Yang, Jiong
    AMERICAN JOURNAL OF INFECTION CONTROL, 2013, 41 (10) : 880 - 884
  • [25] Incidence of nosocomial pneumonia in a medical intensive care unit and general medical ward patients in a public hospital in Bombay, India
    Merchant, M
    Karnad, DR
    Kanbur, AA
    JOURNAL OF HOSPITAL INFECTION, 1998, 39 (02) : 143 - 148
  • [26] Clinical and microbiological features of patients admitted to the intensive care unit with nursing and healthcare-associated pneumonia
    Lee, Myoung Kyu
    Kim, Sang-Ha
    Yong, Suk Joong
    Shin, Kye Chul
    Park, Hyeon Cheol
    Choi, Jiwon
    Choi, Yeun Seoung
    Seong, Jae Ho
    Jung, Ye-Ryung
    Lee, Won-Yeon
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2015, 43 (02) : 236 - 249
  • [27] Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit
    AlvarezLerma, F
    Pellus, AM
    Sanchez, BA
    Ortiz, EP
    Jorda, R
    Barcenilla, F
    Maravi, E
    Galvan, B
    Palomar, M
    Serra, J
    Bermejo, B
    Mateu, A
    Quintana, E
    Palacios, MS
    Giral, R
    Gonzalez, V
    Lerma, FA
    Mesa, JL
    Melgarejo, JA
    Martinez, J
    Insausti, J
    Olaechea, P
    Chanovas, M
    Gilabert, A
    Junquera, C
    Valles, J
    Palacios, F
    Calvo, R
    Mesalles, E
    Nava, J
    Santos, A
    Armengol, S
    Marzo, D
    INTENSIVE CARE MEDICINE, 1996, 22 (05) : 387 - 394
  • [28] Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome
    Ferrer, Miquel
    Filippo Difrancesco, Leonardo
    Liapikou, Adamantia
    Rinaudo, Mariano
    Carbonara, Marco
    Li Bassi, Gianluigi
    Gabarrus, Albert
    Torres, Antoni
    CRITICAL CARE, 2015, 19
  • [29] Potential Impact of Hospital-acquired Pneumonia Guidelines on Empiric Antibiotics An Evaluation of 113 Veterans Affairs Medical Centers
    Bostwick, A. Doran
    Jones, Barbara E.
    Paine, Robert
    Goetz, Matthew Bidwell
    Samore, Matthew
    Jones, Makoto
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (11) : 1392 - 1398
  • [30] Outcomes in patients with community-acquired pneumonia admitted to the intensive care unit
    Cavallazzi, Rodrigo
    Wiemken, Timothy
    Arnold, Forest W.
    Luna, Carlos M.
    Bordon, Jose
    Kelley, Robert
    Feldman, Charles
    Chalmers, James D.
    Torres, Antoni
    Ramirez, Julio
    RESPIRATORY MEDICINE, 2015, 109 (06) : 743 - 750